Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
EULAR Rheumatology Open|June 29, 2026
Global perspectives on rheumatology training: insights from the EULAR 2025 EMEUNET Presents sessionLatika Gupta, Alexandros Panagiotopoulos, Dzifa Dey, et al.
Clinical and Experimental Gastroenterology|June 17, 2021
Diminished Non-Classical Monocytes in the Blood Associate with Disease Severity in Alcoholic HepatitisElisabeth Busk Rasmussen, Lotte Lindgreen Eriksen, Stinne Ravn Greisen, et al.
Arthritis Research & Therapy|February 15, 2022
Tumor necrosis factor alpha neutralization attenuates immune checkpoint inhibitor-induced activation of intermediate monocytes in synovial fluid mononuclear cells from patients with inflammatory arthritisAnne Sofie Sørensen, Morten Nørgaard Andersen, Kristian Juul-Madsen, et al.
Clinical Proteomics|August 13, 2020
Proteomic analysis of synovial fluid from rheumatic arthritis and spondyloarthritis patientsSvend Birkelund, Tue Bjerg Bennike, Kenneth Kastaniegaard, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 13, 2019
Anti-tumor necrosis factor treatment increases both the Th17 and Th22 T helper subsets in spondyloarthritisThomas Andersen, René Drage Østgård, Maithri Prasad Aspari, et al.
Scandinavian Journal of Immunology|June 7, 2024
Fibroblast activation protein and disease severity, progression, and survival in idiopathic pulmonary fibrosisThomas Skovhus Prior, Nils Hoyer, Jesper Rømhild Davidsen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 1, 2022
Comparison of immune checkpoint inhibitor-induced arthritis and reactive arthritis to inform therapeutic strategyAnders Kirkegaard Jensen, Katerina Chatzidionysiou, Christopher Kirkegaard Torp, et al.
Autoimmunity Reviews|December 16, 2020
Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatmentMads Brüner, Anders Dige, Anne Gitte Loft, et al.
Scientific Reports|November 13, 2021
Phenotypic and functional characterization of synovial fluid-derived fibroblast-like synoviocytes in rheumatoid arthritisDitte Køster, Johanne Hovgaard Egedal, Søren Lomholt, et al.
Arthritis Research & Therapy|September 25, 2014
CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'Stinne Ravn Greisen, Karen Kræmmer Schelde, Tue Kruse Rasmussen, et al.
Pageof 5